Discontinuation report RAN-NABILONE

Last updated on 2018-06-01 History
Report ID 50992
Drug Identification Number 02358085
Brand name RAN-NABILONE
Common or Proper name RAN-NABILONE
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Active Ingredient(s) NABILONE
Strength(s) 0.5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-05-31
Actual discontinuation date 2018-05-31
Remaining supply date 2018-05-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2018-06-01 English Compare
v2 2018-05-31 French Compare
v1 2018-05-31 English Compare